Conclusions and recommendations from the symposium, Beyond Cholesterol: Prevention and Treatment of Coronary Heart Disease with n-3 Fatty Acids

American Journal of Clinical Nutrition

Volumn 87, Issue 6, 2008, Pages

  Deckelbaum, Richard J ^a   Leaf, Alexander ^b   Mozaffarian, Dariush ^c   Jacobson, Terry A ^d   Harris, William S ^e   Akabas, Sharon R ^a,f  

^a New York Presbyterian Morgan Stanley Children's Hospital   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF SOUTH DAKOTA   (United States)

^f Clinical Nutrition   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID;

ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; CONSENSUS; FAT INTAKE; HEALTH CARE POLICY; HEART ARRHYTHMIA; HUMAN; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; MEDICAL LITERATURE; MEDICAL RESEARCH; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIMARY PREVENTION; SECONDARY PREVENTION; SUDDEN DEATH;

EID: 45749117117     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/87.6.2010s     Document Type: Conference Paper

References (12)

1. Mozaffarian D. Fish and n-3 fatty acids for the prevention of fatal coronary heart disease and sudden cardiac death. Am J Clin Nutr 2008; 87(suppl):1991S-6S.
2. Deckelbaum RJ, Akabas SR. n-3 fatty acids and cardiovascular disease: navigating toward recommendations. Am J Clin Nutr 2006;84:1-2.
3. Yokoyama M, Origasa H, Matsuzaki M, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007;369:1090-8.
4. Wang S, Harris WS, Chung M, et al. n-3 Fatty acids from fish or fish-oil supplements, but not α-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr 2006;84:5-17.
5. Jacobson TA. Role of n-3 fatty acids in the treatment of hypertriglyceridemia and cardiovascular disease. Am J Clin Nutr 2008;87(suppl): 1981S-90S.
6. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999;354:447-55.
7. Carpentier YA, Portois L, Malaisse WJ. n-3 fatty acids and the metabolic syndrome. Am J Clin Nutr, 2006;83:S1499-504S.
8. Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 2006;296:1885-99.
9. Leaf A, Albert CM, Josephson M, et al. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation 2005; 112:2762-8.
10. Leaf A. Prevention of sudden cardiac death by n-3 polyunsaturated fatty acids. J Cardiovasc Med 2007;8:S27-9.
11. Torrejon C, Jung UJ, Deckelbaum RJ. n-3 fatty acids and cardiovascular disease: actions and molecular mechanisms. Prostaglandins Leukot Essent Fatty Acids 2007;77:319-26.
12. Domanski MJ. Primary prevention of coronary artery disease. N Engl J Med 2007;357:1543-5.